Keynesonomics

NBI - Is a Pullback Imminent in the Biotech Sector?

NASDAQ:NBI   NASDAQ Biotechnology
0
In aggregate, the impressive move in biotechnology has truly been one for the books, but is it sustainable? Although the fundamentals remain intact (biotech is a growth story and, indubitably, one that's here to stay), I think it is fair to assume that we could see a pullback of at least 10% at some point in the near future. What goes up, must come down. The million dollar question is when, and by how much?

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.